about
Reducing the burden of Herpes Zoster in ItalyThe 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its UseImpact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia.The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.Emerging drugs for varicella-zoster virus infections.Presentation and management of herpes zoster (shingles) in the geriatric population.Herpes zoster surveillance using electronic databases in the Valencian Community (Spain).5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability.Mindfulness meditation in older adults with postherpetic neuralgia: a randomized controlled pilot study.Influence of anatomic location of lidocaine patch 5% on effectiveness and tolerability for postherpetic neuralgia.Preventing and managing herpes zoster: key actions to foster healthy aging.Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients.FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study.Ultrasound-guided peripheral nerve interventions for common pain disorders.
P2860
Q26998625-C88F5887-8191-4E22-944E-527E08F3A3EDQ28069535-95E45FD1-4A1E-4521-8FE6-F2F0D9A14F17Q31040173-E6CF7184-15DE-43D9-A626-716DFA84AC0CQ33611436-F7CD840D-E38C-4B74-9982-F52330040206Q34027426-BCAF3630-FECC-483E-95D1-B11008FA5ED4Q34352218-5BB27378-C924-4C73-9A25-439C24CFD422Q35008196-012DF0A4-6037-426C-895D-73081DF22D95Q35752545-8543E40A-4A18-455C-8C5D-27F2D1F878F4Q35807694-9CFA0A1F-D3C0-4A2B-9D88-17E496AE9E2AQ36958237-948F34E0-1CA6-4DE3-80A4-EBB28E14881BQ38416454-9E481A37-5F6C-42AF-9A02-03EBC8800CF6Q39025692-CB930542-8CE0-4339-95F0-BBEC9FA7EFA5Q40429173-82A5330C-D0B4-4BFA-AAC1-EF6F212C2312Q48231410-8EF826CC-9551-44C9-8F7B-CD360BB5A535Q49693513-D68F6846-D0D2-42A6-92D5-80BE702FB569Q51761737-D7AE4BD3-BB8A-414F-AE91-19845F5C3ED2Q54505432-E7705D44-BC13-48DA-BD39-6725C3C390D9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Postherpetic neuralgia in the elderly.
@en
Postherpetic neuralgia in the elderly.
@nl
type
label
Postherpetic neuralgia in the elderly.
@en
Postherpetic neuralgia in the elderly.
@nl
prefLabel
Postherpetic neuralgia in the elderly.
@en
Postherpetic neuralgia in the elderly.
@nl
P2860
P1476
Postherpetic neuralgia in the elderly.
@en
P2093
J McElhaney
R W Johnson
P2860
P304
P356
10.1111/J.1742-1241.2009.02089.X
P577
2009-09-01T00:00:00Z